June 9 and 10, 2006
2 hours of Optometric or Assistant CE
Once again, we present the Distinguished Dr. Emerson Woodruff and Dr. Clair Bobier Lectures. All optometrists, optometric assistants & staff, and interested people are welcome to join us for these very special events. This year, we are pleased to present two outstanding Canadian speakers.
The first, the Woodruff Lecture, is on Friday, June 9 at 4:45 pm. The second, the Bobier Lecture, is on Saturday, June 10 at 4:45 pm.
Both lectures are held at the School in lecture hall 347 in conjunction with our annual CE weekend. Directions to the School can be found on our Contact Us page.
The lectures are free of charge to all however we ask that, if you are not already registered for the annual CE program, you register with Elizabeth.
Woodruff Lecture
On Friday, June 9 at 4:45 pm, the 12th annual lecture to honour Dr. Emerson Woodruff and his significant contributions to the School of Optometry will be presented.
Dr. Jocelyn Faubert
Perceptual signatures for normal and abnormal neurobiological alterations: Beyond acuity measures
Assessing visual function is an integral part of the Optometric practice as it helps in the diagnosis and determines the consequences of visual anomalies. In this talk, Dr. Faubert will present evidence that perceptual assessment can be extremely useful for both distinguishing and identifying the different neurobiological changes that occur with normal aging, autism and fragile X. Central to the review is how characteristic perceptual abilities, referred to as perceptual signatures, can be used to suggest a neural etiology that is specific to each condition. Dr. Faubert will review evidence from studies assessing both motion and form perception and how the resulting perceptual signatures are interpreted within the context of two main hypotheses regarding information processing: the pathway- and complexity-specific hypotheses. Dr. Faubert will present evidence suggesting that specific neural etiologies based on perceptual abilities can only be made when particular experimental paradigms are used.
Jocelyn Faubert is a full professor at the Université de Montréal School of Optometry and he is the NSERC-Essilor Chair on Presbyopia and Visual Perception. He is an expert on matters of visual perception, full immersion virtual reality, applied optics and neuropsychology of vision.
Dr. Faubert’s research has been published in a number of major scientific journals and in 1999 he received the MRC-Scientist Award. He holds international and US patents for devices that non-invasively measure on-line metabolic activity of the human retina.
Dr. Faubert is a member of the Université de Montréal Neurological Science Research Centre and Institute of Biomedical Engineering. Jocelyn Faubert earned his degrees in experimental psychology from Concordia University (BA 1984, MA 1986 and PhD 1991). In 1991 he received an FCAR award to do postdoctoral work at Harvard University and in the same year he was offered a professor position at Université de Montréal where he has been ever since. He has supervised a number of graduate students in a variety of areas including neuropsychology, biomedical engineering, neurosciences, electrical and computer engineering, kinesiology and vision sciences.
Please join us afterwards for a wine and cheese reception.
Bobier Lecture
On Saturday, June 10 at 4:45 pm, the 17th annual Dr. Clair Bobier Lecture in Vision will be presented to honour Dr. Clair Bobier’s immense contributions to the Optometric profession.
Dr. Brenda Gallie
The World Retinoblastoma Citizen
Dr. Brenda Gallie is an Ophthalmologist who has focused on the rare cancer in children, retinoblastoma. She is Director of the Retinoblastoma Program at The Hospital for Sick Children, a Senior Scientist at the Ontario Cancer Institute, and Professor of Ophthalmology, Molecular and Medical Genetics, and Medical Biophysics, University of Toronto.
Dr. Gallie's research team has contributed significantly to the basic molecular understanding of cancer in general, to applications for molecular diagnosis in healthcare and to clinical trials with novel Internet use. She founded World Retinoblastoma, which is dedicated to creating a worldwide network of centers of excellence in retinoblastoma clinical care and to working with governments and institutions to achieve access for every family to optimal care while maintaining family structures. She leads a basic research lab discovering oncogenes and tumor suppressor genes that promote malignant progression of a rare developing retinal cell to retinoblastoma. From 15 years of translational research to develop efficient and effective technologies to identify mutations for retinoblastoma families, Dr. Gallie has founded a not-for-profit company, Retinoblastoma Solutions, which facilitates mutation testing on a world basis.
